A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts

Brown, H.K., Ottewell, P.D., Evans, C.A. et al. (2 more authors) (2012) A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts. Journal of Bone Oncology, 1. pp. 47-56. ISSN 2212-1374

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2012 Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Keywords: Bone metastasis; Breast cancer; Bisphosphonate; Combination therapy
Dates:
  • Published: September 2012
  • Published (online): 19 June 2012
  • Accepted: 22 May 2012
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 12 Apr 2016 13:55
Last Modified: 12 Apr 2016 13:55
Status: Published
Publisher: Elsevier
Refereed: Yes

Share / Export